Genomic and transcriptomic alterations associated with drug vulnerabilities and prognosis in adenocarcinoma at the gastroesophageal junction
Adenocarcinoma at the gastroesophageal junction has a dismal prognosis and few drug options. Here, the authors present genomic and transcriptomic features and potential therapeutic targets and prognostic biomarkers of Chinese and Caucasian tumours, and reveal the molecular similarities.
Guardado en:
Autores principales: | Yuan Lin, Yingying Luo, Yanxia Sun, Wenjia Guo, Xuan Zhao, Yiyi Xi, Yuling Ma, Mingming Shao, Wen Tan, Ge Gao, Chen Wu, Dongxin Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c436c63633644f689042acf518860914 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas
por: Antonio Pellino, et al.
Publicado: (2021) -
Colonic interposition for recurrent Gastroesophageal junction adenocarcinoma of stomach: a case report
por: Sujan Regmee, et al.
Publicado: (2020) -
Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repair
por: Dewalt RI, et al.
Publicado: (2014) -
Adenocarcinoma of the Gastroesophageal Junction with Synchronous Renal Cell Carcinoma: A Case Report and Literature Review
por: Yankov G., et al.
Publicado: (2020) -
Customization of therapy for gastroesophageal adenocarcinoma patients
por: Dilsa Mizrak Kaya, et al.
Publicado: (2018)